Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 2Breast 2Gynecologic 1Genitourinary 1

Conditions

Lung Neoplasms 2Reperfusion Injury 1End Stage Liver Disease 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Analgesia, Patient-Controlled × Thoracic × Clear all
NCT02040662 2017-06-12

Comparison of Efficacy of Paravertebral and Epidural Analgesia After Videothoracoscopic Lung Lobectomy

Pulmonary Hospital Zakopane

Phase 2 Completed
120 enrolled
Thoracic

Lung Neoplasms

NCT01932918 2015-07-23

Antinociceptive Modalities on Ischemia Reperfusion Injury

National Taiwan University Hospital

Completed
142 enrolled
Thoracic

Lung Neoplasms, Reperfusion Injury, End Stage Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡